Chemoinformaics analysis of 6-acetyl-2,2-dimethyl-2H-1-benzopyran
| Molecular Weight | 202.253 | nRot | 1 |
| Heavy Atom Molecular Weight | 188.141 | nRig | 12 |
| Exact Molecular Weight | 202.099 | nRing | 2 |
| Solubility: LogS | -3.561 | nHRing | 1 |
| Solubility: LogP | 3.11 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 32.6491 |
| nHD | 0 | BPOL | 16.6489 |
| QED | 0.654 |
| Synth | 2.444 |
| Natural Product Likeliness | 1.626 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.973 |
| Pgp-sub | 0 |
| HIA | 0.006 |
| CACO-2 | -4.542 |
| MDCK | 0.0000234 |
| BBB | 0.216 |
| PPB | 0.9332 |
| VDSS | 1.017 |
| FU | 0.0527313 |
| CYP1A2-inh | 0.982 |
| CYP1A2-sub | 0.823 |
| CYP2c19-inh | 0.886 |
| CYP2c19-sub | 0.465 |
| CYP2c9-inh | 0.567 |
| CYP2c9-sub | 0.858 |
| CYP2d6-inh | 0.86 |
| CYP2d6-sub | 0.629 |
| CYP3a4-inh | 0.282 |
| CYP3a4-sub | 0.394 |
| CL | 4.954 |
| T12 | 0.553 |
| hERG | 0.042 |
| Ames | 0.014 |
| ROA | 0.082 |
| SkinSen | 0.533 |
| Carcinogencity | 0.859 |
| EI | 0.823 |
| Respiratory | 0.827 |
| NR-Aromatase | 0.034 |
| Antiviral | No |
| Prediction | 0.607191 |